1 Introduction to Research & Analysis Reports
1.1 Bromodomain Containing Protein 2 Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bromodomain Containing Protein 2 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bromodomain Containing Protein 2 Overall Market Size
2.1 Global Bromodomain Containing Protein 2 Market Size: 2022 VS 2029
2.2 Global Bromodomain Containing Protein 2 Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Bromodomain Containing Protein 2 Sales: 2018-2029
3 Company Landscape
3.1 Top Bromodomain Containing Protein 2 Players in Global Market
3.2 Top Global Bromodomain Containing Protein 2 Companies Ranked by Revenue
3.3 Global Bromodomain Containing Protein 2 Revenue by Companies
3.4 Global Bromodomain Containing Protein 2 Sales by Companies
3.5 Global Bromodomain Containing Protein 2 Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Bromodomain Containing Protein 2 Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Bromodomain Containing Protein 2 Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bromodomain Containing Protein 2 Players in Global Market
3.8.1 List of Global Tier 1 Bromodomain Containing Protein 2 Companies
3.8.2 List of Global Tier 2 and Tier 3 Bromodomain Containing Protein 2 Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Bromodomain Containing Protein 2 Market Size Markets, 2022 & 2029
4.1.2 ZEN-3694
4.1.3 FT-1101
4.1.4 CPI-0610
4.1.5 RG-6146
4.1.6 TTI-281
4.1.7 Others
4.2 By Type – Global Bromodomain Containing Protein 2 Revenue & Forecasts
4.2.1 By Type – Global Bromodomain Containing Protein 2 Revenue, 2018-2023
4.2.2 By Type – Global Bromodomain Containing Protein 2 Revenue, 2024-2029
4.2.3 By Type – Global Bromodomain Containing Protein 2 Revenue Market Share, 2018-2029
4.3 By Type – Global Bromodomain Containing Protein 2 Sales & Forecasts
4.3.1 By Type – Global Bromodomain Containing Protein 2 Sales, 2018-2023
4.3.2 By Type – Global Bromodomain Containing Protein 2 Sales, 2024-2029
4.3.3 By Type – Global Bromodomain Containing Protein 2 Sales Market Share, 2018-2029
4.4 By Type – Global Bromodomain Containing Protein 2 Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Bromodomain Containing Protein 2 Market Size, 2022 & 2029
5.1.2 Colon Cancer
5.1.3 Lung Cancer
5.1.4 Myelofibrosis
5.1.5 Refractory Multiple Myeloma
5.1.6 Others
5.2 By Application – Global Bromodomain Containing Protein 2 Revenue & Forecasts
5.2.1 By Application – Global Bromodomain Containing Protein 2 Revenue, 2018-2023
5.2.2 By Application – Global Bromodomain Containing Protein 2 Revenue, 2024-2029
5.2.3 By Application – Global Bromodomain Containing Protein 2 Revenue Market Share, 2018-2029
5.3 By Application – Global Bromodomain Containing Protein 2 Sales & Forecasts
5.3.1 By Application – Global Bromodomain Containing Protein 2 Sales, 2018-2023
5.3.2 By Application – Global Bromodomain Containing Protein 2 Sales, 2024-2029
5.3.3 By Application – Global Bromodomain Containing Protein 2 Sales Market Share, 2018-2029
5.4 By Application – Global Bromodomain Containing Protein 2 Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Bromodomain Containing Protein 2 Market Size, 2022 & 2029
6.2 By Region – Global Bromodomain Containing Protein 2 Revenue & Forecasts
6.2.1 By Region – Global Bromodomain Containing Protein 2 Revenue, 2018-2023
6.2.2 By Region – Global Bromodomain Containing Protein 2 Revenue, 2024-2029
6.2.3 By Region – Global Bromodomain Containing Protein 2 Revenue Market Share, 2018-2029
6.3 By Region – Global Bromodomain Containing Protein 2 Sales & Forecasts
6.3.1 By Region – Global Bromodomain Containing Protein 2 Sales, 2018-2023
6.3.2 By Region – Global Bromodomain Containing Protein 2 Sales, 2024-2029
6.3.3 By Region – Global Bromodomain Containing Protein 2 Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Bromodomain Containing Protein 2 Revenue, 2018-2029
6.4.2 By Country – North America Bromodomain Containing Protein 2 Sales, 2018-2029
6.4.3 US Bromodomain Containing Protein 2 Market Size, 2018-2029
6.4.4 Canada Bromodomain Containing Protein 2 Market Size, 2018-2029
6.4.5 Mexico Bromodomain Containing Protein 2 Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Bromodomain Containing Protein 2 Revenue, 2018-2029
6.5.2 By Country – Europe Bromodomain Containing Protein 2 Sales, 2018-2029
6.5.3 Germany Bromodomain Containing Protein 2 Market Size, 2018-2029
6.5.4 France Bromodomain Containing Protein 2 Market Size, 2018-2029
6.5.5 U.K. Bromodomain Containing Protein 2 Market Size, 2018-2029
6.5.6 Italy Bromodomain Containing Protein 2 Market Size, 2018-2029
6.5.7 Russia Bromodomain Containing Protein 2 Market Size, 2018-2029
6.5.8 Nordic Countries Bromodomain Containing Protein 2 Market Size, 2018-2029
6.5.9 Benelux Bromodomain Containing Protein 2 Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Bromodomain Containing Protein 2 Revenue, 2018-2029
6.6.2 By Region – Asia Bromodomain Containing Protein 2 Sales, 2018-2029
6.6.3 China Bromodomain Containing Protein 2 Market Size, 2018-2029
6.6.4 Japan Bromodomain Containing Protein 2 Market Size, 2018-2029
6.6.5 South Korea Bromodomain Containing Protein 2 Market Size, 2018-2029
6.6.6 Southeast Asia Bromodomain Containing Protein 2 Market Size, 2018-2029
6.6.7 India Bromodomain Containing Protein 2 Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Bromodomain Containing Protein 2 Revenue, 2018-2029
6.7.2 By Country – South America Bromodomain Containing Protein 2 Sales, 2018-2029
6.7.3 Brazil Bromodomain Containing Protein 2 Market Size, 2018-2029
6.7.4 Argentina Bromodomain Containing Protein 2 Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Bromodomain Containing Protein 2 Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Bromodomain Containing Protein 2 Sales, 2018-2029
6.8.3 Turkey Bromodomain Containing Protein 2 Market Size, 2018-2029
6.8.4 Israel Bromodomain Containing Protein 2 Market Size, 2018-2029
6.8.5 Saudi Arabia Bromodomain Containing Protein 2 Market Size, 2018-2029
6.8.6 UAE Bromodomain Containing Protein 2 Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 F. Hoffmann-La Roche Ltd
7.1.1 F. Hoffmann-La Roche Ltd Company Summary
7.1.2 F. Hoffmann-La Roche Ltd Business Overview
7.1.3 F. Hoffmann-La Roche Ltd Bromodomain Containing Protein 2 Major Product Offerings
7.1.4 F. Hoffmann-La Roche Ltd Bromodomain Containing Protein 2 Sales and Revenue in Global (2018-2023)
7.1.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.2 Forma Therapeutics Inc
7.2.1 Forma Therapeutics Inc Company Summary
7.2.2 Forma Therapeutics Inc Business Overview
7.2.3 Forma Therapeutics Inc Bromodomain Containing Protein 2 Major Product Offerings
7.2.4 Forma Therapeutics Inc Bromodomain Containing Protein 2 Sales and Revenue in Global (2018-2023)
7.2.5 Forma Therapeutics Inc Key News & Latest Developments
7.3 Incyte Corp
7.3.1 Incyte Corp Company Summary
7.3.2 Incyte Corp Business Overview
7.3.3 Incyte Corp Bromodomain Containing Protein 2 Major Product Offerings
7.3.4 Incyte Corp Bromodomain Containing Protein 2 Sales and Revenue in Global (2018-2023)
7.3.5 Incyte Corp Key News & Latest Developments
7.4 Merck & Co Inc
7.4.1 Merck & Co Inc Company Summary
7.4.2 Merck & Co Inc Business Overview
7.4.3 Merck & Co Inc Bromodomain Containing Protein 2 Major Product Offerings
7.4.4 Merck & Co Inc Bromodomain Containing Protein 2 Sales and Revenue in Global (2018-2023)
7.4.5 Merck & Co Inc Key News & Latest Developments
7.5 Nuevolution AB
7.5.1 Nuevolution AB Company Summary
7.5.2 Nuevolution AB Business Overview
7.5.3 Nuevolution AB Bromodomain Containing Protein 2 Major Product Offerings
7.5.4 Nuevolution AB Bromodomain Containing Protein 2 Sales and Revenue in Global (2018-2023)
7.5.5 Nuevolution AB Key News & Latest Developments
7.6 Resverlogix Corp
7.6.1 Resverlogix Corp Company Summary
7.6.2 Resverlogix Corp Business Overview
7.6.3 Resverlogix Corp Bromodomain Containing Protein 2 Major Product Offerings
7.6.4 Resverlogix Corp Bromodomain Containing Protein 2 Sales and Revenue in Global (2018-2023)
7.6.5 Resverlogix Corp Key News & Latest Developments
7.7 Trillium Therapeutics Inc
7.7.1 Trillium Therapeutics Inc Company Summary
7.7.2 Trillium Therapeutics Inc Business Overview
7.7.3 Trillium Therapeutics Inc Bromodomain Containing Protein 2 Major Product Offerings
7.7.4 Trillium Therapeutics Inc Bromodomain Containing Protein 2 Sales and Revenue in Global (2018-2023)
7.7.5 Trillium Therapeutics Inc Key News & Latest Developments
8 Global Bromodomain Containing Protein 2 Production Capacity, Analysis
8.1 Global Bromodomain Containing Protein 2 Production Capacity, 2018-2029
8.2 Bromodomain Containing Protein 2 Production Capacity of Key Manufacturers in Global Market
8.3 Global Bromodomain Containing Protein 2 Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Bromodomain Containing Protein 2 Supply Chain Analysis
10.1 Bromodomain Containing Protein 2 Industry Value Chain
10.2 Bromodomain Containing Protein 2 Upstream Market
10.3 Bromodomain Containing Protein 2 Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Bromodomain Containing Protein 2 Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界のブロモドメイン含有タンパク質 2市場予測2023-2029：ZEN-3694、FT-1101、CPI-0610、RG-6146、TTI-281、その他 |
| 【英語タイトル】Bromodomain Containing Protein 2 Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5733 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：76 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界のブロモドメイン含有タンパク質 2市場規模と予測を収録しています。・世界のブロモドメイン含有タンパク質 2市場：売上、2018年-2023年、2024年-2029年 ・世界のブロモドメイン含有タンパク質 2市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のブロモドメイン含有タンパク質 2市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ZEN-3694」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ブロモドメイン含有タンパク質 2のグローバル主要企業は、F. Hoffmann-La Roche Ltd、 Forma Therapeutics Inc、 Incyte Corp、 Merck & Co Inc、 Nuevolution AB、 Resverlogix Corp、 Trillium Therapeutics Incなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ブロモドメイン含有タンパク質 2のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のブロモドメイン含有タンパク質 2市場：タイプ別、2018年-2023年、2024年-2029年 世界のブロモドメイン含有タンパク質 2市場：タイプ別市場シェア、2022年 ・ZEN-3694、FT-1101、CPI-0610、RG-6146、TTI-281、その他 世界のブロモドメイン含有タンパク質 2市場：用途別、2018年-2023年、2024年-2029年 世界のブロモドメイン含有タンパク質 2市場：用途別市場シェア、2022年 ・結腸がん、肺がん、骨髄線維症、難治性多発性骨髄腫、その他 世界のブロモドメイン含有タンパク質 2市場：地域・国別、2018年-2023年、2024年-2029年 世界のブロモドメイン含有タンパク質 2市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるブロモドメイン含有タンパク質 2のグローバル売上、2018年-2023年 ・主要企業におけるブロモドメイン含有タンパク質 2のグローバル売上シェア、2022年 ・主要企業におけるブロモドメイン含有タンパク質 2のグローバル販売量、2018年-2023年 ・主要企業におけるブロモドメイン含有タンパク質 2のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 F. Hoffmann-La Roche Ltd、 Forma Therapeutics Inc、 Incyte Corp、 Merck & Co Inc、 Nuevolution AB、 Resverlogix Corp、 Trillium Therapeutics Inc ************************************************************* ・調査・分析レポートの概要 ブロモドメイン含有タンパク質 2市場の定義 市場セグメント 世界のブロモドメイン含有タンパク質 2市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のブロモドメイン含有タンパク質 2市場規模 世界のブロモドメイン含有タンパク質 2市場規模：2022年 VS 2029年 世界のブロモドメイン含有タンパク質 2市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのブロモドメイン含有タンパク質 2の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のブロモドメイン含有タンパク質 2製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ZEN-3694、FT-1101、CPI-0610、RG-6146、TTI-281、その他 ブロモドメイン含有タンパク質 2のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：結腸がん、肺がん、骨髄線維症、難治性多発性骨髄腫、その他 ブロモドメイン含有タンパク質 2の用途別グローバル売上・予測 ・地域別市場分析 地域別ブロモドメイン含有タンパク質 2市場規模 2022年と2029年 地域別ブロモドメイン含有タンパク質 2売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） F. Hoffmann-La Roche Ltd、 Forma Therapeutics Inc、 Incyte Corp、 Merck & Co Inc、 Nuevolution AB、 Resverlogix Corp、 Trillium Therapeutics Inc ... |
This report aims to provide a comprehensive presentation of the global market for Bromodomain Containing Protein 2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bromodomain Containing Protein 2. This report contains market size and forecasts of Bromodomain Containing Protein 2 in global, including the following market information:
Global Bromodomain Containing Protein 2 Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Bromodomain Containing Protein 2 Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Bromodomain Containing Protein 2 companies in 2022 (%)
The global Bromodomain Containing Protein 2 market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
ZEN-3694 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Bromodomain Containing Protein 2 include F. Hoffmann-La Roche Ltd, Forma Therapeutics Inc, Incyte Corp, Merck & Co Inc, Nuevolution AB, Resverlogix Corp and Trillium Therapeutics Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bromodomain Containing Protein 2 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bromodomain Containing Protein 2 Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Bromodomain Containing Protein 2 Market Segment Percentages, by Type, 2022 (%)
ZEN-3694
FT-1101
CPI-0610
RG-6146
TTI-281
Others
Global Bromodomain Containing Protein 2 Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Bromodomain Containing Protein 2 Market Segment Percentages, by Application, 2022 (%)
Colon Cancer
Lung Cancer
Myelofibrosis
Refractory Multiple Myeloma
Others
Global Bromodomain Containing Protein 2 Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Bromodomain Containing Protein 2 Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bromodomain Containing Protein 2 revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Bromodomain Containing Protein 2 revenues share in global market, 2022 (%)
Key companies Bromodomain Containing Protein 2 sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Bromodomain Containing Protein 2 sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
F. Hoffmann-La Roche Ltd
Forma Therapeutics Inc
Incyte Corp
Merck & Co Inc
Nuevolution AB
Resverlogix Corp
Trillium Therapeutics Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bromodomain Containing Protein 2, market overview.
Chapter 2: Global Bromodomain Containing Protein 2 market size in revenue and volume.
Chapter 3: Detailed analysis of Bromodomain Containing Protein 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bromodomain Containing Protein 2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Bromodomain Containing Protein 2 capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界のブロモドメイン含有タンパク質 2市場予測2023-2029：ZEN-3694、FT-1101、CPI-0610、RG-6146、TTI-281、その他] (コード：MMG23JU5733)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のブロモドメイン含有タンパク質 2市場予測2023-2029：ZEN-3694、FT-1101、CPI-0610、RG-6146、TTI-281、その他]についてメールでお問い合わせ |
